No relief for RBS investors

RBS, Britain’s remaining semi-nationalised bank, has just paid a special dividend – but shareholders are anything but happy. Matthew Partridge reports.

Ross McEwan, CEO of RBS © Jason Alden/Bloomberg via Getty Images

Ross McEwan: no successor has yet been named
(Image credit: Ross McEwan, CEO of RBS © Jason Alden/Bloomberg via Getty Images)

On Friday, the Royal Bank of Scotland (RBS) announced that it had made £2bn in net profit, its "best result for more than a decade", reports Sean Farrell in The Guardian. As a result, it will pay a total of £1.7bn in dividends for the first half of its financial year, partly funded by the sale of a stake in a Saudi Arabian bank. It's only the second time that shareholders have received money since the end of 2007. Naturally, the biggest winner will be the government, which will receive around £1bn, thanks to the fact that it still owns 62% of RBS.

Ross McEwan, the chief executive, argues that the decision to pay a special dividend means the bank is finally "serving the real economy of the UK and the Republic of Ireland", says Harriet Russell in The Daily Telegraph. However, investors evidently beg to differ the news actually "caused a slump in the bank's share price". This was due to the fact that RBS not only "missed analysts' expectations for its underlying net income", but also indicated that it is "unlikely" to achieve certain targets next year because of "Brexit-related economic and political uncertainty".

A long stay in purgatory beckons for RBS

Brexit is far from the only problem that RBS has to face, adds Elisa Martinuzzi on Bloomberg. Other issues include "trade tensions, low interest rates and fierce competition in the UK mortgage market". There's also the risk of RBS "being broken up" in the event that a hard-left government led by Jeremy Corbyn takes power. That's not to mention the lingering impact of "a string of expensive legal settlements over past misdeeds", from "benchmark-rigging" to the marketing of "toxic" mortgage-backed securities. Given all these problems, RBS (and its shareholders) look to be stuck in an "uncomfortable purgatory" for a while longer.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Given RBS's problems, it is more important than ever that a successor to McEwan, who will be departing for Australia early next year, is found as soon as possible, says Ben Martin in The Times. However, while the City is "eager to learn" who will fill the New Zealander's shoes, there was "no update" on RBS's succession plan, other than that the bank is making "good progress". At the moment, the leading internal candidates for the role are Alison Rose and Mark Bailie, while HSBC's Ian Stuart has also been "sounded out".

Dr Matthew Partridge

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri